S&P 500   3,974.61 (+1.88%)
DOW   31,899.53 (+2.04%)
QQQ   293.51 (+1.67%)
AAPL   142.67 (+3.69%)
MSFT   259.91 (+2.91%)
FB   194.50 (+0.50%)
GOOGL   2,230.83 (+2.42%)
AMZN   2,151.41 (-0.02%)
TSLA   675.00 (+1.67%)
NVDA   168.16 (+0.73%)
BABA   86.82 (+0.03%)
NIO   15.79 (-3.95%)
AMD   94.69 (+1.27%)
CGC   5.18 (-6.16%)
MU   69.33 (+0.62%)
T   20.88 (+2.35%)
GE   75.98 (+0.97%)
F   12.86 (+2.88%)
DIS   105.35 (+2.86%)
AMC   11.70 (-2.74%)
PFE   53.08 (+1.16%)
PYPL   81.11 (+0.71%)
NFLX   185.81 (-0.29%)
S&P 500   3,974.61 (+1.88%)
DOW   31,899.53 (+2.04%)
QQQ   293.51 (+1.67%)
AAPL   142.67 (+3.69%)
MSFT   259.91 (+2.91%)
FB   194.50 (+0.50%)
GOOGL   2,230.83 (+2.42%)
AMZN   2,151.41 (-0.02%)
TSLA   675.00 (+1.67%)
NVDA   168.16 (+0.73%)
BABA   86.82 (+0.03%)
NIO   15.79 (-3.95%)
AMD   94.69 (+1.27%)
CGC   5.18 (-6.16%)
MU   69.33 (+0.62%)
T   20.88 (+2.35%)
GE   75.98 (+0.97%)
F   12.86 (+2.88%)
DIS   105.35 (+2.86%)
AMC   11.70 (-2.74%)
PFE   53.08 (+1.16%)
PYPL   81.11 (+0.71%)
NFLX   185.81 (-0.29%)
S&P 500   3,974.61 (+1.88%)
DOW   31,899.53 (+2.04%)
QQQ   293.51 (+1.67%)
AAPL   142.67 (+3.69%)
MSFT   259.91 (+2.91%)
FB   194.50 (+0.50%)
GOOGL   2,230.83 (+2.42%)
AMZN   2,151.41 (-0.02%)
TSLA   675.00 (+1.67%)
NVDA   168.16 (+0.73%)
BABA   86.82 (+0.03%)
NIO   15.79 (-3.95%)
AMD   94.69 (+1.27%)
CGC   5.18 (-6.16%)
MU   69.33 (+0.62%)
T   20.88 (+2.35%)
GE   75.98 (+0.97%)
F   12.86 (+2.88%)
DIS   105.35 (+2.86%)
AMC   11.70 (-2.74%)
PFE   53.08 (+1.16%)
PYPL   81.11 (+0.71%)
NFLX   185.81 (-0.29%)
S&P 500   3,974.61 (+1.88%)
DOW   31,899.53 (+2.04%)
QQQ   293.51 (+1.67%)
AAPL   142.67 (+3.69%)
MSFT   259.91 (+2.91%)
FB   194.50 (+0.50%)
GOOGL   2,230.83 (+2.42%)
AMZN   2,151.41 (-0.02%)
TSLA   675.00 (+1.67%)
NVDA   168.16 (+0.73%)
BABA   86.82 (+0.03%)
NIO   15.79 (-3.95%)
AMD   94.69 (+1.27%)
CGC   5.18 (-6.16%)
MU   69.33 (+0.62%)
T   20.88 (+2.35%)
GE   75.98 (+0.97%)
F   12.86 (+2.88%)
DIS   105.35 (+2.86%)
AMC   11.70 (-2.74%)
PFE   53.08 (+1.16%)
PYPL   81.11 (+0.71%)
NFLX   185.81 (-0.29%)
LON:COS

Collagen Solutions plc (COS.L) (COS) Share Forecast, Price & News

GBX 6.62
0.00 (0.00%)
(As of 11/16/2020)
Add
Compare
Today's Range
6.63
6.63
50-Day Range
6.63
6.63
52-Week Range
0.70
6.95
Volume
15,000 shs
Average Volume
298,181 shs
Market Capitalization
£30.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive COS News and Ratings via Email

Sign-up to receive the latest news and ratings for Collagen Solutions plc (COS.L) and its competitors with MarketBeat's FREE daily newsletter.

About Collagen Solutions plc (COS.L)

Collagen Solutions plc sources, develops, manufactures, and supplies medical grade collagen components and biomaterials for use in research, regenerative medicines, medical devices, and in-vitro diagnostics in Europe, the Middle East, Africa, North America, and Asia. It offers collagen soluble collagen, collagen powders, fibrillars, collagen gels, freeze dried collagen, and other products for use in orthopaedic, sports medicine, dental, wound care, cardiovascular, general, plastic, and reconstructive surgeries, as well as 3D cell culture research; Bovine Pericardium is used in bio-prosthetic heart valves, dural closures, bone and dental membranes, and surgical buttressing applications; and BSE-free bovine biomaterials. The company also provides product development and contract manufacturing services, including technology transfer and regulatory support services for collagen-based products. It serves pharmaceutical and medical device companies. Collagen Solutions plc was incorporated in 2013 and is based in London, the United Kingdom.

Headlines

UBER Jul 2021 45.500 put
See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
48
Year Founded
N/A

Sales & Book Value

Annual Sales
£4.01 million
Cash Flow
GBX 0.50 per share
Book Value
GBX 4 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£30.99 million
Optionable
Not Optionable

Company Calendar

Last Earnings
7/31/2020
Today
5/23/2022

MarketRank

Overall MarketRank

0.96 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













Collagen Solutions plc (COS.L) (LON:COS) Frequently Asked Questions

How were Collagen Solutions plc (COS.L)'s earnings last quarter?

Collagen Solutions plc (COS.L) (LON:COS) announced its quarterly earnings data on Friday, July, 31st. The company reported ($0.76) EPS for the quarter.
View Collagen Solutions plc (COS.L)'s earnings history
.

Who are Collagen Solutions plc (COS.L)'s key executives?
Collagen Solutions plc (COS.L)'s management team includes the following people:
  • Mr. Jamal D. Rushdy, CEO & Director (Age 48, Pay $243.5k)
  • Ms. Hilary G. Spence, CFO, Company Sec. & Director
  • Mr. Tom Hyland, Chief Technical Adviser (Age 55, Pay $72.1k)
  • Dr. John Higgins, Chief Technology Officer
  • Ms. Lisa Baderoon, Head of Investor Relations
  • Mr. Brad Selman, VP of Global Sales & Marketing
  • Ms. Diane Mitchell MBA, Chief Commercial Officer
  • Mr. Kevin Darling, VP of Tissue Products & MD of New Zealand
  • Ms. Gillian Nancy Black, Company Sec. (Age 57)
  • Dr. Stewart White Ph.D., MBA, Consultant & Member of Scientific Advisory Board (Age 49)
What other stocks do shareholders of Collagen Solutions plc (COS.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Collagen Solutions plc (COS.L) investors own include ReNeuron Group (RENE), Sareum (SAR), Oxford Biomedica (OXB), ValiRx (VAL), Active Energy Group (AEG), Norcros (NXR), Oxford Instruments (OXIG), Proteome Sciences (PRM), Perseus Mining (PRU) and Nektar Therapeutics (NKTR).

What is Collagen Solutions plc (COS.L)'s stock symbol?

Collagen Solutions plc (COS.L) trades on the London Stock Exchange (LON) under the ticker symbol "COS."

How do I buy shares of Collagen Solutions plc (COS.L)?

Shares of COS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Collagen Solutions plc (COS.L)'s stock price today?

One share of COS stock can currently be purchased for approximately GBX 6.63.

How much money does Collagen Solutions plc (COS.L) make?

Collagen Solutions plc (COS.L) has a market capitalization of £30.99 million and generates £4.01 million in revenue each year.

How many employees does Collagen Solutions plc (COS.L) have?

Collagen Solutions plc (COS.L) employs 48 workers across the globe.

What is Collagen Solutions plc (COS.L)'s official website?

The official website for Collagen Solutions plc (COS.L) is www.collagensolutions.com.

How can I contact Collagen Solutions plc (COS.L)?

Collagen Solutions plc (COS.L)'s mailing address is Nova Business Park, 3 Robroyston Oval, GLASGOW, G33 1AP, United Kingdom. The company can be reached via phone at +44-141-6489100.

This page was last updated on 5/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.